VaxEquity Ltd

The positive Phase III results and subsequent US approval of lecanemab for Alzheimer’s disease was reflected by a spike in enthusiasm for the central nervous system (CNS) space among the 90 or so resp

The UK government and pharma and biotech trade associations have heralded a potentially long-term partnership inked with Moderna, Inc. that plans to build an mRNA vaccine research and manufacturing

If Sanofi seems late to the party in announcing results for its messenger RNA (mRNA) vaccine against COVID-19, that’s because it is no longer even advancing that COVID-19 program but is using the ea